Cleared Traditional

K844034 - SONOCARE

K844034 is an FDA 510(k) clearance for SONOCARE, manufactured by Echo Ultrasound. The device is a Class 1 Dental device with product code DYO cleared through the Traditional 510(k) pathway after a 99-day FDA review.

K844034 · Echo Ultrasound · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1985
Decision
99d
Days
Class 1
Risk

K844034 is an FDA 510(k) clearance for the SONOCARE. Classified as Band, Material, Orthodontic (product code DYO), Class I - General Controls.

Submitted by Echo Ultrasound (Lewistown, US). The FDA issued a Cleared decision on January 23, 1985 after a review of 99 days - within the typical 510(k) review window.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.5410 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Echo Ultrasound devices

FDA 510(k) Submission Details - K844034

510(k) Number K844034 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 16, 1984
Decision Date January 23, 1985
Days to Decision 99 days
Submission Type Traditional
Review Panel Dental (DE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
28d faster than avg
Panel avg: 127d · This submission: 99d
Pathway characteristics
Predicate-based equivalence.

DYO Device Classification - Class 1, General Controls

Product Code DYO Band, Material, Orthodontic
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 872.5410
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.